Koji Sasaki1, Hagop Kantarjian1, Farhad Ravandi1, Nicholas Short1, Naval Daver1, Naveen Pemmaraju1, Deborah Thomas1, Musa Yilmaz1, Tapan Kadia1, Rebecca Garris1, Guillermo Garciamanero1, Courtney Dinardo1, Marina Konopleva1, Zeev Estrov1, Jain Nitin1, William Wierda1, Vicki Jeanis1, Jorge Cortes1, Susan Obrien2, Elias Jabbour1 (1.Houston, TX, U.S.A., 2.University of California, Irvine, CA, U.S.A.)
Session information
Oral Session
Oral Session 1-12D ALL: Clinical Trials
Fri. Oct 11, 2019 4:30 PM - 5:30 PM No.12 (Tokyo International Forum, 5F G510)
Chair: Yoshihiro Hatta (Hematology and Rheumatology, Nihon University School of Medicine)
Isamu Sugiura1, Noriko Doki2, Tomoko Hata3, Ryuko Cho4, Toshiro Ito5, Yoko Suehiro6, Heiwa Kanamori7, Shinichi Kako8, Mitsuhiro Matsuda9, Hisayuki Yokoyama10, Yasuhiro Taniguchi11, Maki Hagihara12, Yukiyasu Ozawa13, Shin Fujisawa14, Nobuaki Dobashi15, Yoshihiro Hatta16, Noboru Asada17, Kazuteru Ohashi2, Yasushi Onishi18, Shiro Koh19, Satoshi Nishiwaki20, Yoshiko Atsuta21, Fumihiko Hayakawa22, Shigeki Ohtake23, Yasushi Miyazaki3 (1.Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan, 2.Hematology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 3.Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan, 4.Hematology, Chibaken Saiseikai Narashino Hospital, Chiba, Japan, 5.Hematology, Matsumoto Medical Center, Matsumoto, Japan, 6.Hematology, National Kyushu Cancer Center, Fukuoka, Japan, 7.Hematology, Kanagawa Cancer Center, Yokohama, Japan, 8.Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan, 9.Hematology, PL General Hospital, 10.Hematology, Sendai Medical Center, Sendai, Japan, 11.Hematology and Rheumatology, Kindai University, Osakasayama, Japan, 12.Hematology and Clinical Immunology, Yokohama City University Hospital, Yokohama, Japan, 13.Hematology, Japanese Red Cross Nagoya First Hospital, Japan, 14.Hematology, Yokohama City University Medical Center, Japan, 15.Clinical Oncology Hematology, Jikei University School of Medicine, Tokyo, Japan, 16.Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 17.Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan, 18.Hematolgy and Rheumatology, Tohoku University Hospital, Sendai, Japan, 19.Hematology, Fuchu Hospital, Fuchu, Japan, 20.Hematology and Oncology, Nagoya University Hospital, Japan, 21.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 22.Pathophysiological Laboratory Sciences, Nagoya University Graduate School Medicine, Nagoya, Japan, 23.Kanazawa University, Kanazawa, Japan)
Koji Sasaki1, Hagop Kantarjian1, Nicholas Short1, Farhad Ravandi1, Maria Khouri1, Guillermo Garciamanero1, Naval Daver1, Tapan Kadia1, Marina Konopleva1, Nitin Jain1, Ghayas Issa1, Jovitta Jacob1, Rebecca Garris1, Musa Yimaz1, Philip Tompson1, Patrice Nasnas1, Naveen Pemmaraju1, Jorge Cortes1, Susan Obrien2, Elias Jabbour1 (1.MD Anderson Cancer Center, Houston, TX, U.S.A., 2.The University of California, Irvine)
Takeshi Saito1, Yoshihiro Hatta2, Fumihiko Hayakawa3, Kiyotoshi Imai4, Yuichi Yahagi1, Tsutomu Takahashi5, Maki Hagihara6, Hiroatsu Iida7, Koichiro Minauchi8, Etsuko Yamazaki9, Isamu Sugiura10, Tohru Murayama11, Toru Sakura12, Naoki Mori13, Yoshiko Atsuta14, Akiko Saito15, Akihiro Hirakawa16, Hitoshi Kiyoi17, Itaru Matsumura18, Yasushi Miyazaki19 (1.Div. of Clinical Oncology/Hematology, The Jikei Univ., Tokyo, 2.Div. of Hematology/Rheumatology, Nihon Univ., Tokyo, 3.Dep. of Pathophysiological Laboratory Sciences, Nagoya Univ., Nagoya, 4.Dep. of Internal Medicine, Miyanomori Hospital, Sapporo, 5.Dep. of Oncology/Hematology, Shimane Univ. Hospital, Izumo, 6.Dep. of Hematology/Clinical Immunology, Yokohama City Univ., Yokohama, 7.National Hospital Organization Nagoya Medical Center, Nagoya, 8.Dep. of Hematology, Sapporo Hokuyu Hospital, Sapporo, 9.Clinical Laboratory Department, Yokohama City Univ., Yokohama, 10.Div. of Hematology/Oncology, Toyohashi Municipal Hospital, Toyohashi, 11.Dep. of Hematology, Hyogo Cancer Center, Akashi, 12.Hematology, Saiseikai Maebashi Hospital, Maebashi, 13.Dep. of Hematology, Tokyo Womens Medical Univ., Tokyo, 14.Japanese Data Cebter for Hematopoietic Cell Transplantation, Nagoya, 15.Clinical Research Center, National Hospital Organization Nagoya Medical Center, 16.Dep. of Biostatics/Bioinformatics, Graduate School of Medicine. Tokyo Univ., Tokyo, 17.Dep. of Hematology/Oncology, Nagoya Univ. Graduate School of Medicine, Nagoya, 18.Dep. of Hematology/Rheumatology, Kindai Univ. Hospital, Faculty of Medicine, Osaka, 19.Dep. of Hematology, Atomic Bomb Institute, Nagasaki Univ., Nagasaki)
Yasushi Onishi1, Davidi I. Marks2, Daniel J. DeAngelo3, Elias Jabbour4, Anjali Advani5, Susan O'Brien6, Tao Wang7, Alexander Neuhof8, Erik Vandendries9, Hagop Kantarjian4, Wendy Stock10, Matthias Stelljes11, Ryand D. Cassaday12 (1.Tohoku University Hospital, Sendai, Japan, 2.University Hospitals Bristol, Bristol, United Kingdom, 3.Dana-Farber Cancer Institute, Boston, MA, USA, 4.University of Texas MD Anderson Cancer Center, Houston, TX, USA, 5.Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA, 6.University of California, Irvine Medical Center, Orange, CA, USA, 7.Pfizer, Inc, Groton, CT, USA, 8.Pfizer Pharma GmbH, Berlin, Germany, 9.Pfizer, Inc, Cambridge, MA, USA, 10.University of California, Irvine Medical Center, Orange, CA, USA, 11.Universitätsklinikum Munster, Germany, 12.University of Washington School of Medicine, FHCRC, Seattle, WA, USA)
Naoki Miyashita1,7, Ryoji Kobayashi2, Takeshi Kondo3, Tomoyuki Endo4, Yutaka Tsutsumi5, Hajime Kobayashi6, Yasutaka Kakinoki7, Satoshi Yamamoto8, Yuichi Konuma9, Takuto Miyagishima10, Tetsuyuki Igarashi11, Takanori Oda12, Hajime Sakai13, Toshimichi Ishihara14, Masahiro Yoshida15, Takahiro Nagashima16, Kazuya Sato17, Yuji Kanisawa18, Yoshihito Haseyama19, Yasuo Hirayama20, Shuichi Ota1, Akio Shigematsu1, Mitsutoshi Kurosawa21 (1.Department of Hematology, Sapporo Hokuyu hospital, Sapporo, Japan, 2.Department of Pediatrics, Sapporo Hokuyu Hospital, Sapporo, Japan, 3.Blood Disorders Center, Aiiku Hospital, Sapporo, Japan, 4.Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan, 5.Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan, 6.Department of Hematology, Obihiro Kosei Hospital, Obihiro, Japan, 7.Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan, 8.Department of Hematology, Sapporo City General Hospital, Sapporo, Japan, 9.Department of Hematology/Oncology, Asahikawa Red Cross Hospital, Asahikawa, Japan, 10.Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan, 11.Department of Hematology, Tenshi Hospital, Sapporo, Japan, 12.Department of Hematology/Oncology, Hokkaido Medical Center for Child Health, 13.Department of Hematology, Teine Keijinkai Hospital, Sapporo, Japan, 14.Department of Hematology, Kin-ikyo Chuo Hospital, Sapporo, Japan, 15.Department of Hematology/Oncology, Steel Memorial Muroran Hospital, Muroran, Japan, 16.Department of Internal Medicine, Japanese RC Kitami Hospital, Kitami, Japan, 17.Department of Hematology/Oncology, Asahikawa Kosei Hospital, Asahikawa, Japan, 18.Department of Hematology/Oncology, Oji General Hospital, Tomakomai, Japan, 19.Department of Hematology, Tonan Hospital, Sapporo, Japan, 20.Department of Internal Medicine, Higashi Sapporo Hospital, Sapporo, Japan, 21.Department of Hematology, Hokkaido Cancer Center, Sapporo, Japan)